Literature DB >> 25666010

Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study.

O O Olatosi1, E O Sote, O O Orenuga.   

Abstract

BACKGROUND: Pulpotomy is the common therapy for cariously exposed pulps in symptom-free primary molar teeth. Formocresol (FC) is considered the gold standard dressing agent for pulpotomy, but concerns have been raised over the years about its safety. Other alternative pulpotomy agents have been investigated and suggested.
OBJECTIVE: The objective was to evaluate and compare the clinical and radiographic response of FC and white mineral trioxide aggregate (MTA) as pulpotomy materials on primary molars.
MATERIALS AND METHODS: Fifty primary molars, with deep carious lesion that exposed a vital but asymptomatic pulp, in 37 children aged 4-7 years were treated with conventional pulpotomy procedure. The teeth were divided randomly into two groups. Group I (FC) and group II (MTA). The treated teeth were evaluated clinically and radiographically and were followed-up for 12 months.
RESULTS: At the end of the 12 months follow-up, the clinical success rates for FC and MTA were 81% and 100%, respectively. There was a statistically significant difference ( P = 0.04) between the clinical success rates of FC and MTA. While the radiographic success rates for FC and MTA were 81% and 96%, respectively, there was no statistically significant difference between the radiographic success of MTA and FC.
CONCLUSION: White MTA showed a higher clinical and radiographic success rate when compared to FC as a pulpotomy agent in vital primary molars, and it has a potential to become a replacement for FC in primary molars.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25666010     DOI: 10.4103/1119-3077.151071

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  8 in total

1.  Clinical Evaluation of Low Level Diode Laser Application For Primary Teeth Pulpotomy.

Authors:  K S Uloopi; C Vinay; A Ratnaditya; A Satya Gopal; K J N Mrudula; R Chandrasekhar Rao
Journal:  J Clin Diagn Res       Date:  2016-01-01

2.  Clinical and Radiographic Evaluation of Pulpotomy using MTA, Biodentine and Er,Cr:YSGG Laser in primary teeth- A Clinical Study.

Authors:  Pandiyan Ramanandvignesh; Kumar Gyanendra; Dhillon Jatinder Kaur Goswami Mridula
Journal:  Laser Ther       Date:  2020-07-17

Review 3.  Pulp treatment for extensive decay in primary teeth.

Authors:  Violaine Smaïl-Faugeron; Anne-Marie Glenny; Frédéric Courson; Pierre Durieux; Michele Muller-Bolla; Helene Fron Chabouis
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

4.  Difference of Success Rates of Mineral Trioxide Aggregate Pulpotomies Performed Both by Undergraduate Dental Students and by an Expert Operator: A Retrospective Study.

Authors:  Marco Pasini; Maria Rita Giuca; Roberto Gatto; Silvia Caruso
Journal:  ScientificWorldJournal       Date:  2017-08-24

5.  Measurement Reliability of the Remaining Dentin Thickness below Deep Carious Lesions in Primary Molars.

Authors:  Roula Berbari; Alexandre Khairallah; Hussein F Kazan; Mohamad Ezzedine; Daniel Bandon; Elia Sfeir
Journal:  Int J Clin Pediatr Dent       Date:  2017-02-01

6.  Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial.

Authors:  Randa Youssef Abd Al Gawad; Rasha Mohamed Hatem Hanafy
Journal:  Saudi Dent J       Date:  2020-08-29

Review 7.  Different Pulp Dressing Materials for the Pulpotomy of Primary Teeth: A Systematic Review of the Literature.

Authors:  Maurizio Bossù; Flavia Iaculli; Gianni Di Giorgio; Alessandro Salucci; Antonella Polimeni; Stefano Di Carlo
Journal:  J Clin Med       Date:  2020-03-19       Impact factor: 4.241

8.  Clinical and radiographic evaluation of different materials in primary molar pulpotomies: A retrospective study.

Authors:  Chih-Yu Lin; Chun-Liang Kuo; Cheng-Yu Hsieh; Jen-Chang Yang; Kai-Ti Chang; Hsiao-Ting Huang; Sung-Chih Hsieh; Nai-Chia Teng
Journal:  J Dent Sci       Date:  2019-09-12       Impact factor: 2.080

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.